Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUS, INTRAVESICULAR, OPHTHALMICGeneric

RADIOGENIX SYSTEM

TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

Standard Dose
30-1153mCi/GENERATOR
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview RADIOGENIX SYSTEM is listed in Drugs@FDA under application 202158 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR Form and strength SOLUTION;INTRAVENOUS, INTRAVESICULAR, OPHTHALMIC - 30-1153mCi/GENERATOR Sponsor NORTHSTAR MEDICAL Submission history Latest submission status date: 2021-07-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview RADIOGENIX SYSTEM is listed in Drugs@FDA under application 202158 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR Form and strength SOLUTION;INTRAVENOUS, INTRAVESICULAR, OPHTHALMIC - 30-1153mCi/GENERATOR Sponsor NORTHSTAR MEDICAL Submission history Latest submission status date: 2021-07-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
RADIOGENIX SYSTEM (TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR) | Drug Monograph | MedicHelpline